FindTrial
Sign In

The Enhanced Value of PET/CT Health Organ Radiomics in Predicting the Prognosis of Non Small Cell Lung Cancer

The Enhanced Value of PET/CT Health Organ Radiomics in Predicting the Prognosis of Non Small Cell Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114034
Enrollment
Unknown
Registered
2025-12-05
Start date
2025-12-05
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Gold Standard:Pathological result
Index test:SUVmax

Sponsors

Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with non-small cell lung cancer; 2.Prior to receiving treatment, a 18F-FDG PET/CT imaging examination was performed; 3.Having complete clinical and follow-up information.

Exclusion criteria

Exclusion criteria: 1. Incomplete or poor quality image data; 2.Patients with other serious underlying diseases affecting prognosis assessment; 3.Patients who refuse to participate in this study;

Design outcomes

Primary

MeasureTime frame
Overall survival period;—

Secondary

MeasureTime frame
Progression-free survival;Recurrence time;Recurrence site;—

Countries

China

Contacts

Public ContactXingyu Mu

Affiliated Hospital of Guilin Medical University

138887664@qq.com+86 773 282 5568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026